rs267607072

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate

The NM_003073.5(SMARCB1):​c.92A>G​(p.Glu31Gly) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E31V) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)

Consequence

SMARCB1
NM_003073.5 missense, splice_region

Scores

10
8
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 6.22

Publications

1 publications found
Variant links:
Genes affected
SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
SMARCB1 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • intellectual disability, autosomal dominant 15
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • rhabdoid tumor predisposition syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • SMARCB1-related schwannomatosis
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
  • familial multiple meningioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schwannomatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 24 uncertain in NM_003073.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr22-23787261-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 8031.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant 22-23787261-A-G is Pathogenic according to our data. Variant chr22-23787261-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 2764125.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003073.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCB1
NM_003073.5
MANE Select
c.92A>Gp.Glu31Gly
missense splice_region
Exon 1 of 9NP_003064.2
SMARCB1
NM_001362877.2
c.92A>Gp.Glu31Gly
missense splice_region
Exon 1 of 9NP_001349806.1
SMARCB1
NM_001317946.2
c.92A>Gp.Glu31Gly
missense splice_region
Exon 1 of 9NP_001304875.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCB1
ENST00000644036.2
MANE Select
c.92A>Gp.Glu31Gly
missense splice_region
Exon 1 of 9ENSP00000494049.2
SMARCB1
ENST00000407422.8
TSL:1
c.92A>Gp.Glu31Gly
missense splice_region
Exon 1 of 9ENSP00000383984.3
SMARCB1
ENST00000263121.12
TSL:1
c.92A>Gp.Glu31Gly
missense splice_region
Exon 1 of 8ENSP00000263121.8

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
27
GnomAD4 genome
Cov.:
33

ClinVar

ClinVar submissions as Germline
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
35
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
D
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.92
D
M_CAP
Pathogenic
0.92
D
MetaRNN
Pathogenic
0.86
D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
6.2
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-4.5
D
REVEL
Pathogenic
0.87
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.0030
D
Polyphen
0.99
D
Vest4
0.63
MutPred
0.46
Gain of glycosylation at S30 (P = 0.0377)
MVP
0.95
MPC
2.1
ClinPred
1.0
D
GERP RS
3.2
PromoterAI
-0.14
Neutral
Varity_R
0.78
gMVP
0.99
Mutation Taster
=8/92
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
1.0
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267607072; hg19: chr22-24129448; API